1.
B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension
by Holditch, Sara J
Hypertension (Dallas, Tex. 1979), 2015, Vol.66 (1), p.199-210
2.
Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons
by Li, Dan
Hypertension (Dallas, Tex. 1979), 2015, Vol.66 (1), p.190-198
3.
The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure
by Nishikimi, Toshio
Heart, 2012, Vol.98 (2), p.152-161
4.
Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts
by Horio, Takeshi
Endocrinology (Philadelphia), 2003, Vol.144 (6), p.2279-2284
5.
Increased Connective Tissue Growth Factor Relative to Brain Natriuretic Peptide as a Determinant of Myocardial Fibrosis
by Koitabashi, Norimichi
Hypertension (Dallas, Tex. 1979), 2007, Vol.49 (5), p.1120-1127
6.
Placental Expression of proBNP/NT-proBNP and Plasma Levels of NT-proBNP in Early- and Late-Onset Preeclampsia
by Junus, Katja
American journal of hypertension, 2014, Vol.27 (9), p.1225-1230
7.
8.
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
by Zannad, Faiez, Prof
The Lancet (British edition), 2015, Vol.385 (9982), p.2067-2076
9.
Molecular forms of natriuretic peptides in heart failure and their implications
by Xu-Cai, Ye Olivia
Heart (British Cardiac Society), 2010, Vol.96 (6), p.419-424
10.
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort
by Labaki, Wassim W
Respiratory medicine, 2018, Vol.140, p.87-93
11.
Cardiac Natriuretic Peptide Gene Expression and Plasma Concentrations During the First 72 Hours of Life in Piglets
by Smith, Julie
Endocrinology (Philadelphia), 2013, Vol.154 (5), p.1864-1872
12.
Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general p...
by Groenning, B A
Heart (British Cardiac Society), 2004, Vol.90 (3), p.297-303
13.
Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice
by James, Michael L
Journal of neurotrauma, 2010, Vol.27 (1), p.217-228
14.
Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure
by Isakova, Tamara
Pediatric nephrology (Berlin, West), 2013, Vol.28 (10), p.2035-2042
15.
NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function
by Bay, M
Heart (British Cardiac Society), 2003, Vol.89 (2), p.150-154
16.
Pathophysiology of sudden cardiac death as demonstrated by molecular pathology of natriuretic peptides in the myocardium
by Chen, Jian-Hua
Forensic science international, 2012, Vol.223 (1), p.342-348
17.
Treadmill exercise in apparently asymptomatic patients with moderate or severe aortic stenosis: relationship between cardiac index and revealed symptoms
by Rajani, Ronak
Heart (British Cardiac Society), 2010, Vol.96 (9), p.689-695
18.
B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells
by Shmilovich, Haim
Tissue engineering. Part A, 2009, Vol.15 (9), p.2741-2749
19.
Long-term outcome of patients with triphasic mitral flow with a mid-diastolic L wave: prognostic role of left atrial volume and N-terminal pro-brain natriuretic peptide
by Kim, Sung-Ai
The International Journal of Cardiovascular Imaging, 2017, Vol.33 (9), p.1377-1384
20.
Prognostic value of N-terminal pro-brain natriuretic peptide in hospitalised patients with community-acquired pneumonia
by Jeong, Ki Young
Emergency medicine journal : EMJ, 2011, Vol.28 (2), p.122-127
